Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heated versus room-temperature oxaliplatin to reduce acute peripheral neuropathy
NL-OMON32647Withdrawn
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Apr 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxaliplatin in colorectal cancer (CRC) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Reduction in acute peripheral neuropathy complaints. Planned start Apr 2009; status: withdrawn.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NL-OMON32647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32647.